G.L. Scherphof
Impact in
- Biochemistry top 5%
- Lipid metabolism and biosynthesis
-
- Immune cells in cancer
- Immunotherapy and Immune Responses
Papers in
-
- Fatty Acid Research and Health 5
-
- Nanoparticle-Based Drug Delivery 4
- Co-authors
- Toos DaemenElisabeth G.E. de VriesL.L.M. Van DeenenL.M.G. Van GoldeFred PossmayerT.M.A.R. DubbelmanJ.W. DijkstraDick Hoekstra
- Journals
- Biochemical Journal (2 papers)Biochimica et Biophysica Acta (BBA) - Biomembranes (2 papers)British Journal of Cancer (1 paper)Journal of Hepatology (1 paper)Journal of Leukocyte Biology (1 paper)
- Partner nations
- NetherlandsUnited StatesRussia
In The Last Decade
G.L. Scherphof
21 papers receiving 875 citations
Peers
Comparison fields: 5 of 90
- Biochemistry 147
- Immunology 210
- Biomaterials 120
- Molecular Biology 463
- Clinical Biochemistry 43
Countries citing papers authored by G.L. Scherphof
This map shows the geographic impact of G.L. Scherphof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.L. Scherphof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.L. Scherphof more than expected).
Fields of papers citing papers by G.L. Scherphof
This network shows the impact of papers produced by G.L. Scherphof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.L. Scherphof. The network helps show where G.L. Scherphof may publish in the future.
Co-authors
The 25 scholars most cited alongside G.L. Scherphof, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 2 | |
| 2 | 2002 | 297 | |
| 3 | 1999 | 28 | |
| 4 | 1997 | 54 | |
| 5 | 1995 | 9 | |
| 6 | 1995 | 22 | |
| 7 | 1994 | 36 | |
| 8 | 1992 | 12 | |
| 9 | 1992 | 12 | |
| 10 | 1991 | 20 | |
| 11 | 1990 | 15 | |
| 12 | A non-exchangeable fluorescent phospholipid analog as a membrane traffic marker of the endocytic pathway. | 1990 | 61 |
| 13 | 1989 | 14 | |
| 14 | 1984 | 88 | |
| 15 | 1982 | 3 | |
| 16 | 1982 | 7 | |
| 17 | 1979 | 19 | |
| 18 | 1976 | 5 | |
| 19 | 1969 | 157 | |
| 20 | 1966 | 38 |
About G.L. Scherphof
G.L. Scherphof is a scholar working on Nutrition and Dietetics, Biomaterials, Biochemistry, Oncology and Immunology, having authored 21 papers that have together received 916 indexed citations. Recurring topics across this work include Lipid Membrane Structure and Behavior (7 papers), Fatty Acid Research and Health (5 papers), Drug Transport and Resistance Mechanisms (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Nanoparticle-Based Drug Delivery (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Mitochondrial Function and Pathology (2 papers) and Erythrocyte Function and Pathophysiology (2 papers). The work is most often cited by research in Biochemistry (147 citations), Immunology (210 citations), Biomaterials (120 citations), Molecular Biology (463 citations) and Clinical Biochemistry (43 citations). G.L. Scherphof has collaborated with scholars based in Netherlands, United States and Russia. Frequent co-authors include Toos Daemen, Elisabeth G.E. de Vries, L.L.M. Van Deenen, L.M.G. Van Golde, Fred Possmayer, T.M.A.R. Dubbelman, J.W. Dijkstra, Dick Hoekstra, Frits H. Roerdink and J. Willem. Their work appears in journals such as Biochemical Journal, Biochimica et Biophysica Acta (BBA) - Biomembranes, British Journal of Cancer, Journal of Hepatology and Journal of Leukocyte Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.